OTCMKTS:MNGPY MAN GRP PLC/ADR (MNGPY) Stock Forecast, Price & News $1.79 +0.03 (+1.42%) (As of 06/17/2019) Add Compare Share Share Today's Range$1.72▼$1.7950-Day Range$1.79▼$1.7952-Week Range$0.77▼$2.37Volume800 shsAverage Volume4,517 shsMarket Capitalization$2.89 billionP/E RatioN/ADividend Yield5.03%Price TargetN/A ProfileProfileChartCompetitorsHeadlinesProfileChartCompetitorsHeadlines About MAN GRP PLC/ADR (OTCMKTS:MNGPY) StockMan Group plc provides alternative investment management services worldwide. The company offers a range of liquid investment products and solutions, which include quantitative and discretionary, long only and long short, and single and multi-manager. It distributes its products and solutions directly to institutions; and to private investors through a network of intermediaries. Man Group plc was founded in 1783 and is headquartered in London, the United Kingdom.Read More Receive MNGPY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for MAN GRP PLC/ADR and its competitors with MarketBeat's FREE daily newsletter. Email Address MNGPY Stock News HeadlinesMay 11, 2023 | businessinsider.comInside Man Group's popular training program for non-tech employees that teaches them skills to automate tasks and reduce errors in their workMay 3, 2023 | marketwatch.comBP PLC ADR falls Wednesday, underperforms marketMay 30, 2023 | Behind the Markets (Ad)The single greatest medical breakthrough of all time?We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.April 16, 2023 | americanbankingnews.comMAN GRP PLC/ADR (OTCMKTS:MNGPY) Share Price Crosses Above 200 Day Moving Average of $1.79April 12, 2023 | americanbankingnews.comFinancial Comparison: MAN GRP PLC/ADR (OTCMKTS:MNGPY) & CI Financial (NYSE:CIXXF)February 28, 2023 | financialpost.comMan Group Beats Hedge Fund Blues With Inflows: The London RushDecember 13, 2022 | wsj.comHedge-Fund Bets Boost Huge Texas Teachers' PensionNovember 4, 2022 | financialpost.comPineBridge, Man Group bet on China as reopening hopes fuel marketsMay 30, 2023 | Behind the Markets (Ad)BREAKING: Tiny biotech successfully treats blindnessThere's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.November 2, 2022 | fortune.comU.S. inflation to moderate, but a recession is ‘inevitable,’ says Man Group hedge fund CEOOctober 5, 2022 | reuters.comBCS.N - Barclays PLC (ADR) | Stock Price & Latest News | ReutersSeptember 17, 2022 | money.usnews.comHSBC Holdings plc - ADRSeptember 10, 2022 | reuters.comGSK plcSeptember 5, 2022 | msn.comAmigo Loans cuts ties with KPMG following ‘competitive tender’July 13, 2022 | finance.yahoo.comBrainsway Ltd. Sponsored ADR (BWAY) Stock Jumps 9.4%: Will It Continue to Soar?July 11, 2022 | msn.comRival Go-Ahead Group bidder 'assessing options' as transport firm sees passenger numbers recoverJune 1, 2022 | financialpost.comMan Group selects Percona for MongoDB supportMarch 1, 2022 | insidermonkey.comHedge Fund and Insider Trading News: Edward Lampert, Greenlight Capital, Bridgewater Associates, Othania Capital, Man Group, APA Corp (US) (APA), Meta Platforms Inc (FB), and MoreFebruary 16, 2022 | insidermonkey.comHedge Fund and Insider Trading News: David Rosen, David Einhorn, Carl Icahn, Brevan Howard Asset Management, Man Group, Archegos Capital Management, Kinnate Biopharma Inc (KNTE), and MoreSeptember 24, 2021 | ft.comHedge funds reap windfall by betting on specialist commodity marketsSeptember 14, 2021 | marketwatch.com: One of the best ways to fight inflation is just to follow the trendJuly 5, 2021 | au.finance.yahoo.comTiziana Life Sciences plc - Distribution Dates for shares and ADRs in Accustem Sciences LimitedJune 17, 2021 | wsj.comHysan Development Co. Ltd. ADRJune 16, 2021 | cnbc.comMeme stocks a 'false market' but will cause a radical shift for cinema industry, Man Group CEO saysMay 22, 2021 | wsj.comVTech Holdings Ltd. ADRMay 14, 2021 | yahoo.comSaint Joseph's College will require all students and staff to be fully vaccinated for fall semesterMay 6, 2021 | markets.businessinsider.comInvizius Announces Successful Series A Financing to Develop Anti-Inflammatory Treatment for HaemodialysisSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive MNGPY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for MAN GRP PLC/ADR and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS Industry Investment Advice Sub-IndustryN/A SectorFinance Current SymbolOTCMKTS:MNGPY CUSIPN/A CIKN/A Webwww.man.com Phone44-20-7144-1000FaxN/AEmployees1,325Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E Ratio11.19 P/E Growth0.8Net IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$1.07 billion Price / Sales2.71 Cash Flow$0.26 per share Price / Cash Flow6.96 Book Value$1.05 per share Price / Book1.70Miscellaneous Outstanding Shares1,616,721,000Free FloatN/AMarket Cap$2.89 billion OptionableNot Optionable Beta1.70 Key ExecutivesMr. Luke EllisCEO & Exec. DirectorMr. Jonathan E. H Sorrell (Age 42)Pres & Exec. Director Mr. Mark Daniel JonesCFO & Exec. DirectorMr. Geoff GalbraithChief Operating OfficerMr. Sandy Campbell RattrayChief Investment OfficerKey CompetitorsCohen & SteersNYSE:CNSMoelis & CompanyNYSE:MCArtisan Partners Asset ManagementNYSE:APAMFederated HermesNYSE:FHILazardNYSE:LAZView All Competitors MNGPY Stock - Frequently Asked Questions How have MNGPY shares performed in 2023? MAN GRP PLC/ADR's stock was trading at $1.79 at the beginning of 2023. Since then, MNGPY shares have increased by 0.0% and is now trading at $1.79. View the best growth stocks for 2023 here. Is MAN GRP PLC/ADR a good dividend stock? MAN GRP PLC/ADR (OTCMKTS:MNGPY) pays an annual dividend of $0.09 per share and currently has a dividend yield of 5.03%. MNGPY has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. Read our dividend analysis for MNGPY. What is MAN GRP PLC/ADR's stock symbol? MAN GRP PLC/ADR trades on the OTCMKTS under the ticker symbol "MNGPY." How do I buy shares of MAN GRP PLC/ADR? Shares of MNGPY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is MAN GRP PLC/ADR's stock price today? One share of MNGPY stock can currently be purchased for approximately $1.79. How much money does MAN GRP PLC/ADR make? MAN GRP PLC/ADR (OTCMKTS:MNGPY) has a market capitalization of $2.89 billion and generates $1.07 billion in revenue each year. How many employees does MAN GRP PLC/ADR have? The company employs 1,325 workers across the globe. How can I contact MAN GRP PLC/ADR? MAN GRP PLC/ADR's mailing address is 2 Swan Lane, London X0, EC4R 3AD. The official website for the company is www.man.com. The financial services provider can be reached via phone at 44-20-7144-1000 or via email at relationshipservices@man.com. This page (OTCMKTS:MNGPY) was last updated on 5/30/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MAN GRP PLC/ADR Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.